Current algorithms for the clinical management of patients with squamous cell carcinoma of
the head and neck (HNSCC) are based on a stage-dependent strategy where all patients at …

The efficacy of concurrent chemoradiotherapy (CTRT) in locally advanced cervix cancer
(LACC, stages IIB-IVA) is contentious. This is due to the variable extent of therapeutic benefit …

Background New ultrasensitive methods for detecting residual disease after surgery are
needed in human papillomavirus–associated oropharyngeal squamous cell carcinoma …

Cetuximab remains to date the only targeted therapy approved for the treatment of head and
neck squamous cell carcinoma (HNSCC). The EGFR pathway plays a key role in the …

Abstract Background Human Papillomavirus oropharyngeal carcinoma (HPVOPC) has
better progression free (PFS) and overall survival (OS) than non-HPVOPC. Standard-dose …

Introduction Technological advancements in treatment planning and delivery have propelled
the use of intensity-modulated radiation therapy (IMRT) in head and neck squamous cell …

We aimed to determine whether pretherapeutic assessment of HPV circulating tumoral DNA
(HPV ctDNA) by droplet‐based digital PCR (ddPCR) could constitute a predictive and …

Purpose Distant metastasis (DM) is the main cause of death for patients with human
papillomavirus (HPV)–related oropharyngeal cancers (OPCs); yet, there are few reliable …

Abstract Background The American Joint Commission on Cancer (AJCC) recently created
new staging for human papillomavirus associated oropharyngeal cancer (HPV+ OPSCC) for …

Background There is significant interest in treatment de-escalation for human papillomavirus-
associated (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) patients given the …